Xylem completes Evoqua acquisition; files Evoqua FY2022 financials: rev $1.74B, net $72.3M

Xylem Inc.

Merger closed May 24, 2023; Evoqua historical financials filed in 8-K/A amendment.
Evoqua FY2022 (Sep 30, 2022) revenue $1.737B, gross profit $536M, net income $72.3M.
Evoqua FY2022 diluted EPS $0.58, basic EPS $0.60.
Pro forma combined financials in Exhibit 99.3 (not included in this excerpt).
Evoqua total assets $2.191B, liabilities $1.481B, equity $710M at Sep 30, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.